(Q34194389)

31 July 2017

1 reference

title

Pathophysiology of preeclampsia and the role of serotonin (English)

1 reference

31 July 2017

0 references

0 references

1 reference

Bolte AC

1

1 reference

31 July 2017

van Geijn HP

series ordinal

2

1 reference

31 July 2017

Dekker GA

series ordinal

3

1 reference

31 July 2017

publication date

1 March 2001

1 reference

31 July 2017

number of pages

10

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

inferred from page(s)

published in

1 reference

31 July 2017

volume

95

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

12-21

1 reference

National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Etiology and pathogenesis of preeclampsia: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Nitric oxide: mediator, murderer, and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Nitric oxide, the endothelium, pregnancy and pre-eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Nitric oxide in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Biology and clinical relevance of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Regulatory functions of the vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Pre-eclampsia: more than pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Central hemodynamic observations in untreated preeclamptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

A study of angiotensin II pressor response throughout primigravid pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Disordered eicosanoid formation in pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

The role of prostaglandins in obstetrical disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Predictive value of increased plasma levels of fibronectin in gestational hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Placental-type plasminogen activator inhibitor in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Early detection of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Biochemical corroboration of endothelial involvement in severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Elevated circulating thrombomodulin in severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Total plasma fibronectin as a marker of pregnancy-induced hypertensive disorders: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Endomyocardial ultrastructural findings in preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

The kidney in toxemia of pregnancy: a clinical and pathologic study based on renal biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Ultrastructural aspects of preeclampsia. II. Mitochondrial changes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Sera of preeclamptic women are not cytotoxic to endothelial cells in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Abnormal endothelial cell function of resistance arteries from women with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Relationship of cell adhesion molecule expression to endothelium-dependent relaxation in normal pregnancy and pregnancies complicated with preeclampsia or fetal growth restriction.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

The role of nitric oxide in the pathogenesis of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

The pathophysiology of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Nitric oxide in preeclampsia: lack of evidence for decreased production

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Preeclampsia: an excessive maternal inflammatory response to pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Endothelial vasoactive mediators in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Plasma endothelin-1 levels in patients with pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Maternal plasma level of endothelin is increased in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Plasma Immunoreactive Endothelin-1 in Pregnant Women With and Without Pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Platelet activation and vascular damage in gestational hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Maternal and fetal plasma concentrations of endothelin, lipidhydroperoxides, glutathione peroxidase and fibronectin in relation to abnormal umbilical artery velocimetry

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Amino acids, glucose and lactate concentrations in umbilical cord blood in relation to umbilical artery flow patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Nitric oxide and prostaglandin systems inhibition on the isolated perfused human placenta from normal and preeclamptic pregnancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Platelets and the beginnings of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

The laboratory evaluation of hypertensive gravidas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Thrombocytopenia in preeclampsia and eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Coagulation changes in eclampsia: Their frequency and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Enhancement of hepatic artery resistance to blood flow in preeclampsia in presence or absence of HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Serotonin (5-hydroxytryptamine)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Effects of a new serotonin antagonist, ketanserin, in experimental and clinical hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

5-Hydroxytryptamine contracts human uterine artery smooth muscle predominantly via 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Pharmacological Characterization of the Postsynaptic Serotonergic Receptor in the Human Uterine Artery

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Systemic and uterine vascular response to serotonin in third trimester pregnant ewes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Placental transfer and maternal and fetal hemodynamic effects of ketanserin in the pregnant ewe

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Serotonin-induced vasoconstriction in human placental chorionic veins: interaction with prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Effects of selected vasoconstrictor agonists on isolated omental artery from premenopausal nonpregnant women and from normal and preeclamptic pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Effect of 5-Hydroxytryptamine and Iproniazid on Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

POSSIBLE ROLE OF 5-HYDROXYTRYPTAMINE IN TOXAEMIA OF PREGNANCY

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Urinary 5-hydroxyindole acetate concentration in pregnancy induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

The possible relation between late pregnancy hypertension and 5-hydroxytryptamine levels in maternal blood

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Veränderungen des Serotoninstoffwechsels bei Präeklampsie

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Recent developments in the pathophysiology and management of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Placental monoamine-oxidase activity in toxaemia of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Novel appearance of placental nuclear monoamine oxidase: biochemical and histochemical evidence for hyperserotonomic state in preeclampsia-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Reactivities to serotonin and histamine in umbilical and placental vessels during the third trimester after normotensive pregnancies and pregnancies complicated by preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Receptor-mediated stimulation of aortic prostacyclin release by 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Lipid peroxidation in pregnancy: new perspectives on preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900367-5

7 January 2021

10.1016/S0301-2115(00)00367-5

Identifiers

DOI

1 reference

31 July 2017

1 reference